27 related articles for article (PubMed ID: 15375522)
1. The expression and prognostic significance of Topo-II and c-erbB-2 in breast cancer.
Hua S; Chuanbo F; Zhonglin W; Shuangjiu Z; Xinwen Z
Minerva Med; 2020 Jul; ():. PubMed ID: 32683851
[TBL] [Abstract][Full Text] [Related]
2. The Significance of Topoisomerase II Alpha in Invasive Breast Carcinoma.
Arthi M; Arun Kumar K; D'Cruze L; S R; Joseph LD; Dev B
Cureus; 2021 Oct; 13(10):e18733. PubMed ID: 34790485
[TBL] [Abstract][Full Text] [Related]
3. Associations between clinicopathological prognostic factors and pAkt, pMAPK and topoisomerase II expression in breast cancer.
Iyikesici MS; Basaran G; Dane F; Ekenel M; Yumuk PF; Cabuk D; Teomete M; Turhal NS
Int J Clin Exp Med; 2014; 7(5):1459-64. PubMed ID: 24995112
[TBL] [Abstract][Full Text] [Related]
4. Topoisomerase II alpha gene amplification is a favorable prognostic factor in patients with HER2-positive metastatic breast cancer treated with trastuzumab.
Fountzilas G; Christodoulou C; Bobos M; Kotoula V; Eleftheraki AG; Xanthakis I; Batistatou A; Pentheroudakis G; Xiros N; Papaspirou I; Koumarianou A; Papakostas P; Bafaloukos D; Skarlos DV; Kalogeras KT
J Transl Med; 2012 Oct; 10():212. PubMed ID: 23092535
[TBL] [Abstract][Full Text] [Related]
5. A novel five gene signature derived from stem-like side population cells predicts overall and recurrence-free survival in NSCLC.
Perumal D; Singh S; Yoder SJ; Bloom GC; Chellappan SP
PLoS One; 2012; 7(8):e43589. PubMed ID: 22952714
[TBL] [Abstract][Full Text] [Related]
6. A comparative analysis of gene-expression data of multiple cancer types.
Xu K; Cui J; Olman V; Yang Q; Puett D; Xu Y
PLoS One; 2010 Oct; 5(10):e13696. PubMed ID: 21060876
[TBL] [Abstract][Full Text] [Related]
7. Proliferation marker securin identifies favourable outcome in invasive ductal breast cancer.
Talvinen K; Tuikkala J; Nevalainen O; Rantanen A; Hirsimäki P; Sundström J; Kronqvist P
Br J Cancer; 2008 Jul; 99(2):335-40. PubMed ID: 18594525
[TBL] [Abstract][Full Text] [Related]
8. Human topoisomerase II-alpha is highly expressed in sinonasal-inverted papilloma, but not in inflammatory polyp.
Hadar T; Shvero J; Yaniv E; Shvili I; Leabu M; Koren R
J Cell Mol Med; 2008; 12(5A):1551-8. PubMed ID: 18544048
[TBL] [Abstract][Full Text] [Related]
9. Mitosis-specific MPM-2 phosphorylation of DNA topoisomerase IIalpha is regulated directly by protein phosphatase 2A.
Escargueil AE; Larsen AK
Biochem J; 2007 Apr; 403(2):235-42. PubMed ID: 17212588
[TBL] [Abstract][Full Text] [Related]
10. Topoisomerase II alpha as a marker predicting anthracyclines' activity in early breast cancer patients: ready for the primetime?
Di Leo A; Biganzoli L; Claudino W; Licitra S; Pestrin M; Larsimont D
Eur J Cancer; 2008 Dec; 44(18):2791-8. PubMed ID: 18993056
[TBL] [Abstract][Full Text] [Related]
11. Correlation between MIB-1 and other proliferation markers: clinical implications of the MIB-1 cutoff value.
Spyratos F; Ferrero-Poüs M; Trassard M; Hacène K; Phillips E; Tubiana-Hulin M; Le Doussal V
Cancer; 2002 Apr; 94(8):2151-9. PubMed ID: 12001111
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of Topoisomerase II in female breast cancer.
Koren R; Rath-Wolfson L; Ram E; Itzhac OB; Schachter B; Klein B; Gal R; Dreznik Z
Oncol Rep; 2004 Oct; 12(4):915-9. PubMed ID: 15375522
[TBL] [Abstract][Full Text] [Related]
13. Topoisomerase IIalpha expression in breast cancer: correlation with outcome variables.
Depowski PL; Rosenthal SI; Brien TP; Stylos S; Johnson RL; Ross JS
Mod Pathol; 2000 May; 13(5):542-7. PubMed ID: 10824926
[TBL] [Abstract][Full Text] [Related]
14. Topoisomerase II alpha expression correlates with diminished disease-free survival in invasive breast cancer.
O'Connor JK; Hazard LJ; Avent JM; Lee RJ; Fischbach J; Gaffney DK
Int J Radiat Oncol Biol Phys; 2006 Aug; 65(5):1411-5. PubMed ID: 16750309
[TBL] [Abstract][Full Text] [Related]
15. Expression of human DNA Topoisomerase II-alpha in squamous cell carcinoma of the larynx and its correlation with clinicopathologic variables.
Shvero J; Koren R; Shvili I; Yaniv E; Sadov R; Hadar T
Am J Clin Pathol; 2008 Dec; 130(6):934-9. PubMed ID: 19019771
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
